Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2264535 | 0.71 | CYP1A2 (0.36) | ALDH1A1 | |
| SCHEMBL4460819 | 0.67 | — | — | |
| SCHEMBL4467536 | 0.67 | ALDH1A1 (0.39) | ALDH1A1MAPT | |
| SCHEMBL2968035 | 0.64 | ALDH1A1 (0.33) | ALDH1A1MAPT | |
| SCHEMBL7435655 | 0.62 | GPR3 (0.36) | TP53CNR1CNR2ALDH1A1MAPT | |
| SCHEMBL5746244 | 0.62 | HTT (0.36) | TP53ALDH1A1 | |
| SCHEMBL3269033 | 0.60 | CYP1A2 (0.35) | ALDH1A1 | |
| SCHEMBL2090417 | 0.60 | CYP2A6 (0.38) | TP53CNR1CNR2ALDH1A1MAPT | |
| SCHEMBL5542574 | 0.59 | TRPA1 (0.35) | ALDH1A1MAPT | |
| SCHEMBL2388976 | 0.58 | CNR2 (0.46) | CNR1CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5401738-A | Angiotensin antagonist, hypotensive, aldosteronism, cardiac insufficiency | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER (DE) | 1995-03-28 | — | — | US | claimed |
| EP-0702013-B1 | Imidazopyridines | MERCK PATENT GMBH (DE) | 2001-06-13 | — | — | EP | disclosed |
| EP-0702013-A2 | Imidazopyridines | MERCK PATENT GmbH (DE) | 1996-03-20 | — | — | EP | disclosed |
| EP-0657452-A1 | Imidazopyridines | MERCK PATENT GmbH (DE) | 1995-06-14 | — | — | EP | disclosed |
| EP-0657454-A1 | Imidazopyridazines being angiotensin II antagonists | MERCK PATENT GmbH (DE) | 1995-06-14 | — | — | EP | disclosed |
| US-5401738-A | Angiotensin antagonist, hypotensive, aldosteronism, cardiac insufficiency | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER (DE) | 1995-03-28 | — | — | US | disclosed |
| US-5389642-A | Exhibit antagonistic properties toward angiotensin(II); useful for treatment of hypertensioni, aldosteronism, cardiac insufficiency, increased intraocular pressure and disorders of the central nervous system | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1995-02-14 | — | — | US | disclosed |
| EP-0628556-A1 | Imidazopyridines | MERCK PATENT GmbH (DE) | 1994-12-14 | — | — | EP | disclosed |
| EP-0602521-A1 | Imidazopyridines | MERCK PATENT GmbH (DE) | 1994-06-22 | — | — | EP | disclosed |
| EP-0595151-A2 | Imidazopyridine derivates as antagonists of angiotensin II | MERCK PATENT GmbH (DE) | 1994-05-04 | — | — | EP | disclosed |
| CN-1086214-A | Di-and triazinedione | MERCK PATENT GMBH (DE) | 1994-05-04 | — | — | CN | disclosed |
| EP-0589201-A1 | Di- and triazindeones | MERCK PATENT GmbH (DE) | 1994-03-30 | — | — | EP | disclosed |
| CN-1082542-A | Benzimidizole derivatives | MERCK PATENT GMBH (DE) | 1994-02-23 | — | — | CN | disclosed |
| CN-1082045-A | Imidazopyridine | MERCK PATENT GMBH (DE) | 1994-02-16 | — | — | CN | disclosed |
| EP-0574787-A2 | Benzimidazole derivatives as angiotensin II antagonists | MERCK PATENT GmbH (DE) | 1993-12-22 | — | — | EP | disclosed |
| EP-0574846-A2 | Imidazopyridines as angiotensin II antagonistes | MERCK PATENT GmbH (DE) | 1993-12-22 | — | — | EP | disclosed |
| EP-0564960-A1 | Imidazopyridines as angiotensin II antagonists | MERCK PATENT GmbH (DE) | 1993-10-13 | — | — | EP | disclosed |
| EP-0547514-A2 | Imidazopyridine derivatives with angiotensin-II antagonist properties | MERCK PATENT GmbH (DE) | 1993-06-23 | — | — | EP | disclosed |